Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Multiple sclerosis is a disease of the central nervous system that is associated with leukocyte recruitment and subsequent inflammation, demyelination and axonal loss. Endothelial vascular cell adhesion molecule-1 (VCAM-1) and its ligand, alpha4beta1 integrin, are key mediators of leukocyte recruitment, and selective inhibitors that bind to the alpha4 subunit of alpha4beta1 substantially reduce clinical relapse in multiple sclerosis. Urgently needed is a molecular imaging technique to accelerate diagnosis, to quantify disease activity and to guide specific therapy. Here we report in vivo detection of VCAM-1 in acute brain inflammation, by magnetic resonance imaging in a mouse model, at a time when pathology is otherwise undetectable. Antibody-conjugated microparticles carrying a large amount of iron oxide provide potent, quantifiable contrast effects that delineate the architecture of activated cerebral blood vessels. Their rapid clearance from blood results in minimal background contrast. This technology is adaptable to monitor the expression of endovascular molecules in vivo in various pathologies.

Original publication

DOI

10.1038/nm1631

Type

Journal article

Journal

Nat Med

Publication Date

10/2007

Volume

13

Pages

1253 - 1258

Keywords

Acute Disease, Animals, Cell Line, Disease Models, Animal, Encephalitis, Endothelial Cells, Ferric Compounds, Injections, Intravenous, Magnetic Resonance Imaging, Male, Mice, Mice, Inbred Strains, Microchemistry, Microinjections, Nanoparticles, Neostriatum, Vascular Cell Adhesion Molecule-1